The contrasting cultures of HIV and tuberculosis care

AIDS

Volumn 29, Issue 1, 2015, Pages 1-4

  Daftary, Amrita ^a,b   Calzavara, Liviana ^c   Padayatchi, Nesri ^b  

^a Department of Medicine   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Co infection; HIV AIDS; Program collaboration; Service integration; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

CULTURAL ANTHROPOLOGY; HEALTH CARE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; STANDARDIZATION; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION; AFRICA SOUTH OF THE SAHARA; HEALTH CARE DELIVERY; HIV INFECTIONS; MIXED INFECTION;

AFRICA SOUTH OF THE SAHARA; COINFECTION; DELIVERY OF HEALTH CARE; HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 84926287980     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000515     Document Type: Note

References (26)

1. WHO. Global tuberculosis control: WHOreport 2011. Geneva: World Health Organization; 2012
2. Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 2009; 374:921-933
3. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367:926-937
4. WHO. TB/HIV Working Group Strategic Plan 2006-2015. Geneva: World Health Organization, Stop TB Partnership; 2006
5. Bayer R, Dubler NN, Gostin LO. The dual epidemics of tuberculosis and AIDS. J Law Med Ethics 1993; 21:277-278
6. Selwyn PA. Tuberculosis and AIDS: epidemiologic, clinical, and social dimensions. J Law Med Ethics 1993; 21:279-288
7. Raviglione MC, Pio A. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet 2002; 359:775-780
8. Macq J, Torfoss T, Getahun H. Patient empowerment in tuberculosis control: reflecting on past documented experiences. Trop Med Int Health 2007; 12:873-885
9. WHO. DOTS Expansion Working Group (DEWG) Strategic Plan 2006-2015. Geneva: World Health Organization, Stop TB Partnership; 2006
10. Akugizibwe P, Ramakant B. Challenges for community role in tuberculosis response. Lancet 2010; 375:2059-2061
11. Wang Y, Collins C, Vergis M, Gerein N, Macq J. HIV/AIDS and TB: contextual issues and policy choice in program relationships. Trop Med Int Health 2007; 12:183-194
12. Gittler J. Controlling resurgent tuberculosis: public health agencies, public policy, and law. J Health Polit Policy Law 1994; 19:107-147
13. Hansell DA. The TB and HIV epidemics: history learned and unlearned. J Law Med Ethics 1993; 21:376-381
14. UNDP. Global commission on HIV and the law: risks, rights and health. New York: United Nations Development Program, HIV/AIDS Group; 2012
15. Harrington M. From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. Clin Infect Dis 2010; 50 (Suppl 3):S260-S266
16. Achmat Z. Science and social justice: the lessons of HIV/AIDS activism in the struggle to eradicate tuberculosis. Int J Tuberc Lung Dis 2006; 10:1312-1317
17. De Waal A. AIDS and power: why there is no political crisis: yet. London & New York: Zed Books; 2006
18. Zachariah R, Harries AD, Srinath S, Ram S, Viney K, Singogo E, et al. Language in tuberculosis services: can we change to patient-centred terminology and stop the paradigm of blaming the patients? Int J Tuberc Lung Dis 2012; 16:714-717
19. Cohen J. Infectious disease. Approval of novel TB drug celebrated: with restraint. Science 2013; 339:130
20. Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004; 9:A11-A15
21. Friedland G, Harries A, Coetzee D. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies. J Infect Dis 2007; 196 (Suppl 1):S114-123
22. Daftary A, Padayatchi N. Integrating patients' perspectives into integrated tuberculosis-human immunodeficiency virus healthcare. Int J Tuberc Lung Dis 2013; 17:546-551
23. O'Donnell MR, Wolf A, Werner L, Horsburgh CR, Padayatchi N. Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: A prospective cohort study. J Acquir Immune Defic Syndr 2014; 67:22-29
24. Daftary A, Padayatchi N, O'Donnell M. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV coinfected patients in South Africa. Glob Public Health 2014; 9:1106-1116
25. WHO. The strategic use of antiretrovirals to help end the HIV epidemic. Geneva: World Health Organization; 2012
26. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morb Mortal Wkly Rep 2006; 55 (RR14):1-17.